Concepedia

Author

Michelle Mojadidi

University of California, Los Angeles

Also Known As

Michelle Mojadidi

15

Publications

344

Citations

5

H-Index

11

Concepts

All Affiliations

University of California, Los AngelesKite (United States)
MM

About

Michelle Mojadidi is an author at University of California, Los Angeles specializing in cancer therapeutics, t cell immunity, and tumor immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

32

2

Immunology

1

1

32

3

Cancer Therapeutics

1

1

32

4

Immunotherapy

1

1

32

5

T Cell Immunity

1

1

32

Michelle Mojadidi

×

5

Publications

333

Citations

5

H-Index

YearCitations

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells

Megan D. Hoban, Dianne Lumaquin, Caroline Y. Kuo,

Molecular Therapy

2016

213

Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases

Michelle Mojadidi, John W. Phillips, Caroline Y. Kuo,

Molecular Therapy — Nucleic Acids

2016

56

A phase I/II clinical trial of E6 T-cell receptor gene therapy for human papillomavirus (HPV)-associated epithelial cancers.

Christian S. Hinrichs, Stacey L. Doran, Sanja Stevanović,

Journal of Clinical Oncology

2017

32

Bioluminescence Imaging of Angiogenesis in a Murine Orthotopic Pancreatic Cancer Model

Eliane Angst, Monica F. Chen, Michelle Mojadidi,

Molecular Imaging and Biology

2010

20

Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Bijal Shah, Wendy Stock, William G. Wierda,

Blood

2017

12

Page 1